In 2004, the National Patient Safety Agency (NSPA) released a safety alert relating to the management and use of infusion devices in England and Wales. The alert called for the standardisation of infusion devices and a consideration of using centralised equipment systems to manage device storage. There has also been growing interest in smart pump technology, such as dose error reduction software (DERS) as a way to reduce IV medication errors. However, questions remain about the progress that has been made towards infusion device standardisation and the adoption of DERS.
Abstract
In 2004, the National Patient Safety Agency (NSPA) released a safety alert relating to the management and use of infusion devices in England and Wales. The alert called for the standardisation of infusion devices and a consideration of using centralised equipment systems to manage device storage. There has also been growing interest in smart pump technology, such as dose error reduction software (DERS) as a way to reduce IV medication errors. However, questions remain about the progress that has been made towards infusion device standardisation and the adoption of DERS.
We report on the results of a survey investigating the extent to which the standardisation of infusion devices has occurred in the last 10 years; how far centralised equipment libraries are being used in practice; and about the prevalence of DERS use within the UK.
The findings indicate that while reported standardisation levels are high, the use of centralised equipment libraries remains low, as does DERS usage.
Introduction
Ten years ago, the National Patient Safety Agency released a safety alert relating to the management and use of infusion devices in England and Wales (NPSA, 2004) . The alert noted that 19% of 700 annual incidents involving intravenous infusions were attributed to user error. In order to reduce the chances of error occurring, it was argued that NHS organisations should review the way in which they purchase, manage and use infusion devices. On the basis of a pilot study in six acute trusts, it was also recommended that organisations providing acute care reduce the range of device types available (where each type has agreed default configurations) and that centralised equipment libraries should be considered a more effective way of managing devices that can also improve patient safety. A toolkit was provided by the NPSA, as well as an audit tool to help organisations make the changes suggested in order to improve patient safety (Quinn, Stevenson & Glenister, 2004) .
As a result, organisations have made changes to purchasing policy (NPSA, 2006) and standardisation has been shown to be effective (Lee, 2010) , where a strategic approach to the ongoing management of infusion devices with board level responsibility is recommended to help maintain the high profile that these high risk devices and therapy demand (MHRA, 2013). However, since 2004, it is unclear the extent to which the standardisation of infusion devices has occurred and how far centralised equipment libraries are being used in practice.
In addition, despite design improvements, user error is still blamed for a large proportion of incidents involving medical infusion devices, up to 21% according to the Medicines and Healthcare Products Regulatory Agency (MHRA, 2013) . Nurses are primary users of infusion devices (Iacovides et al., 2013) , and "smart pump" technology such as Drug Error Reduction Software (DERS) has been presented as beneficial to both nurses and patients (Upton and Quinn, 2013) . While the definition of "smart pump" technology can vary, for the purposes of this review, the term is used to describe infusion devices which require additional information about the patient (e.g. weight) and medication (e.g. drug name, dose, concentration) to be entered and also performs checks to detect possible prescribing and programming errors. In this way, the software performs an "electronic double check" for nurses (Cousins et al, 2013) . Limits for maximum and minimum dosages and infusion rates can be programmed into the associated software which can also be used to form the basis of a risk management plan. Hard limits are fixed and cannot be overridden by the user, whereas soft limits can be temporarily overridden depending on therapy and individual circumstances.
It has been suggested that DERS can help to improve patient safety, particularly in intensive care (Murdoch and Cameron, 2008) , and there are examples of successful implementation within particular hospitals (Cousins et al, 2013) . Furthermore, Keohane et al (2005) highlight the role of the nurse as critical within the selection, implementation and continuing evaluation of smart pump technology. However, it has also been argued that the evidence base for DERS use in practice is currently limited, particularly within the UK (Hertzel and Souza 2009; Taxis and Franklin, 2011, Lee 2013 ). Upton and Quinn (2013) also note that the uptake of DERS within Europe and the UK appears much lower when compared to the USA. The reasons they suggest for this include:
 A lack of standardisation of equipment.  The need for greater hospital pharmacy involvement.
While 68% of hospitals in the USA were found to be using DERS in 2011 (Pedersen et al, 2012 ), there has not been a similar survey to explore the prevalence of use within UK hospitals is (Cousins et al, 2013) . Understanding current usage would help inform future studies of IV infusion safety and DERS usage.
We aimed to address this gap by investigating the following questions in relation to UK hospitals:
1. To what extent are volumetric infusion devices and syringe pumps currently standardised? 2. How are infusion devices currently stored and management?
How is DERS being used and to what extent?

Method
An online survey was sent to infusion device managers and trainers within NHS organisations across the UK between April -July 2013. Respondents were recruited from a previous interview study (Iacovides et al., 2013) , various mailing lists and websites (e.g. the Institute of Physics and Engineering in Medicine mailing list and the National Association of Medical Device Educators and Trainers website) and through attempting to directly contact departments within a list of 162 acute trusts in England (NHS, 2013) . A researcher first contacted each trust's switchboard in order to be put through to the relevant department e.g. Medical Physics, before asking for the contact details of someone responsible for infusion device management. As a result of this process, the survey link was sent to individuals within 83 trusts (in the other cases, the appropriate individual could not be reached). To encourage participation, respondents were given the option to be included in a prize draw where they could win one of three £50 vouchers.
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The survey was hosted online and included questions on standardisation, the pumps in use, how they were stored and accessed, and details of any DERS use.
Results
In total, forty five respondents participated in the study. These included NHS staff who were involved in medical device management, maintenance and/or training within 49 UK organisations (44 trusts in England, 3 health boards in Scotland, and 2 health boards in Wales), representing 120 hospitals (64 acute, 37 community and 19 specialist: e.g. urgent care, cardio-thoracic). These responses have been included in the analysis. The replies to the survey were collated and tabulated for further analysis. 
Standardisation
Participants were asked whether standardisation had occurred across an entire hospital site, within only some clinical areas, or had not taken place at all. Figure 1 indicates that, across 120 hospitals, a high level of standardisation was reported, in relation to both volumetric infusion pumps (n = 92) and syringe pumps (n = 93). Fewer than 20% of hospitals had not standardised across all clinical areas for volumetric pumps (n=23) and syringe pumps (n=22); only 4% reported there was no standardisation at all (n=5).
To further investigate the extent of standardisation, respondents were asked to list which volumetric and syringe pumps were being used within their trusts. Table 1 indicates the different brands of devices that were mentioned in relation to this question (where n refers to the total number of brand mentions). The figures do not indicate individual makes or models of devices in use or variations between device types as detailed information was not always provided by respondents. Of the 39 organisations who reported standardising their devices and where more detailed information about models was provided, the average number of types of volumetric devices listed per trust was 1.3 (range = 1-5). The average number of types of syringe devices was 2.8 per trust (range = 1-9). Table 2 summarises the reported storage and management arrangements of infusion devices in terms of local storage and the use of central libraries across four clinical areas. While some areas use both centralised libraries and local storage systems, the most common approach was to store pumps in local areas only: critical care (62%, n = 50); general medicine (46%, n = 49); general surgery (41%, n = 38) and paediatrics (68%, n = 50). The use of centralised libraries alone does not appear to be very common, particularly within critical care (16%, n = 13) and paediatrics (7%, n = 5). 
Device storage
Use of DERS
Of the 49 respondents, 39 % (n = 19) reported using some form of DERS on at least one site within each organisation. However, the majority (55%, n = 27) were not, and 6% (n = 3) did not know whether DERS had been implemented. Within the 19 organisations using DERS, 74% (n = 14) had DERS implemented on both volumetric and syringe devices, 11% (n = 4) had it enabled only on syringe devices) and the remaining organisation only on volumetric pumps. These figures do not mean that DERS is being used across entire inventories, only that an organisation is using DERS on at least one type of volumetric and/or syringe device. Table 3 indicates that most areas use a mixture of both hard and soft limits: critical care (72%, n = 13); general medicine (70%, n = 7); general surgery (60%, n = 6); paediatrics (63%, n = 5). Out of the respondents, the most common area to utilise DERS was critical care (18 organisations) and the least common was paediatrics (8 organisations). Other specialist areas reported to use DERS include oncology and neonatal intensive care. On a site level, across 24 hospitals implementing DERS, almost all respondents reported updating drug libraries manually, (96%, n = 23), with only one hospital using wireless updates (4%, n = 1). Figure 2 illustrates that within specific hospitals, Critical Care is the most common area for DERS to be used (92%, n = 22). These results also suggest that DERS is not necessarily implemented across all areas within the same hospital. Some respondents also selected "Other areas" of DERS use, with the most popular areas later specified as Neo-natal ICU (22%, n = 5) and Oncology (17%, n = 4).
Figure 2: DERS use across 24 hospital sites
Reasons for not using DERS
Of the 30 organisations who said they were not using DERS, 43% (n = 13) reported that there were no plans to introduce this technology within the next 12 months. Only 20% (n = 6) stated that there was a plan to do so, with a further high proportion of respondents not knowing about future plans (37%, n = 11).
Respondents were asked to explain their choice of answer regarding the future plans for DERS and several reasons were provided for their being no plans to introduce this technology within the next 12 months. For some, this was due to practical issues, such as being tied to an existing device contract e.g. "Existing devices do not have DERS capability and are provided under contract from the OEM [Original Equipment Manufacturer] . This contract has 18-24 months [to run]", (Respondent 43).
In addition, there were concerns about the lack of resources available e.g. "The Trust does not have the resources or infrastructure to implement DERS", (Respondent 7); and the time required to implement DERS and train staff e.g. "Risks of 1) incorrect use of drug error reduction software due to lack of training and high staff turnover and 2) the time and effort required to maintain drug libraries were felt to be significant enough to at least equal the benefits if not outweigh them", (Respondent 36).
Furthermore, there were some issues around not being able to standardise across an entire site e.g.
"There is nothing in the pipeline to my knowledge, the key here is every pump has its own software which talks to its own pump. Problem is each of the softwares will not talk to each other, and standardisation is difficult when certain pumps are purchased for different criteria and application", (Respondent 41) . This particular response also suggests there is an issue concerning lack of interoperability between multiple brands of device.
Discussion
The survey results suggest that in the last 10 years (since the NPSA alert in 2004), progress has been made towards the standardisation of infusion devices. Standardisation is particularly important to achieve before implementing DERS and is likely to aid nurses in their day to day tasks (Cousins et al, 2013) . There is room for improvement however, especially since Lee (2010) has shown that using a multidisciplinary group to help manage and achieve standardisation can reduce clinical risks effectively. There is also an indication that the term "standardisation" may not always mean that one type of pump is being used across the whole hospital as there is still variability in the type of devices used. This is most likely due to specific areas, e.g. critical care and paediatrics, requiring different devices or alternative configurations of the same device. The fact that certain clinical areas require a different set up may be the main reason why centralised equipment libraries are not the most commonly used method of device storage management across entire hospitals.
In addition, this survey provides empirical support regarding the use of DERS in the UK that was previously lacking (Cousins et al, 2013) . The findings indicate that while there are a small number of hospitals and trusts who are starting to implement DERS, but it is less common for this form of technology to be used across an entire site or organisation. The most common usage of DERS appears to be in specialised areas such as Critical Care, with a mixture of hard and soft limits being the most frequent implementation across all areas.
Furthermore, it seems that organisations who wish to implement this type of technology need to overcome several challenges before being able to proceed. Similar to those noted by Upton and Quinn (2013) , these challenges involve practical and organisational issues such as existing device contracts; the infrastructure and resources available; not being convinced that implementing the technology is worth the time and financial investment required, and complications related to a lack of standardisation and communication between devices. The survey findings indicate that many organisations are responsible for multiple sites, which can be at different stages of standardisation and use different types of infusion pumps; this is likely to further complicate the introduction of DERS across entire trusts and health boards.
However, in terms of gathering the data, it was a real challenge to identify individuals who could answer all the questions included for each hospital within a single organisation. Multiple people, including manufacturers, are often involved in the procurement, management and setting up of infusion devices while job titles and departments are not always consistent. This difficulty means that response rates were lower than initially anticipated and also serves to highlight the complexity of working in the area of device management.
This study was the first step in identifying the prevalence of DERS and considering related issues such as standardisation and effective infusion device management. The findings have established a foundation upon which to proceed with further research which is able to consider the effectiveness of DERS and possible recommendations for interventions relating to infusion devices that have greatest potential for aiding nurses in their day to day tasks and increasing patient safety.
